Skip to content
★ Sign in to follow
TM
Total declarations
113
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (27 ops.)
€9.5M

Latest filing published 02 May 2023 for CONMED Corp, €293k.

Filing timeline

BuySale
Terence M. Berge

Insider track record

Disclosed buys
0
Disclosed sells
27
Signal history

Terence M. Berge: trading record in brief

All filings by Terence M. Berge on record concern CONMED Corp. The record holds 113 filings, for trades running from 1 June 2015 to 28 April 2023.

On the market, this insider has only sold: 27 sales, €9.5M in total. Besides market trades, the filings include 36 share grants and 50 option exercises. Since January 2023: no purchases and 4 sales on the market.

The newest entry dates from 2 May 2023: an option exercise of €293k, in CONMED Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Terence M. Berge

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations105 total
  • ◇
    VP-Corporate ControllerExecutivesCONMED Corp
    323,784 USD19SEC
    5,400 shares@ US$59.961.6% of flowCommon StockSEC:0001127602-23-014082:1
  • ◇
    VP-Corporate ControllerExecutivesCONMED Corp
    425,304 USD19SEC
    5,400 shares@ US$78.762.1% of flowCommon StockSEC:0001127602-23-014082:2
  • ◇
    VP-Corporate ControllerExecutivesCONMED Corp
    498,219 USD19SEC
    5,100 shares@ US$97.692.4% of flowCommon StockSEC:0001127602-23-014082:3
  • ▼
    VP-Corporate ControllerExecutivesCONMED Corp
    356,832 USD37SEC
    2,800 shares@ US$127.441.7% of flowCommon StockSEC:0001127602-23-014082:4
  • ▼
    VP-Corporate ControllerExecutivesCONMED Corp
    684,612 USD37SEC
    5,400 shares@ US$126.783.3% of flowCommon StockSEC:0001127602-23-014082:5
  • ▼
    VP-Corporate ControllerExecutivesCONMED Corp
    682,668 USD37SEC
    5,400 shares@ US$126.423.3% of flowCommon StockSEC:0001127602-23-014082:6
  • ▼
    VP-Corporate ControllerExecutivesCONMED Corp
    645,915 USD37SEC
    5,100 shares@ US$126.653.1% of flowCommon StockSEC:0001127602-23-014082:7
  • ◇
    VP-Corporate ControllerExecutivesCONMED Corp
    117,404 USD27SEC
    2,800 shares@ US$41.93100.0% of flowCommon StockSEC:0001127602-23-014082:0
  • ◇
    VP-Corporate ControllerExecutivesCONMED Corp
    153,898 USD19SEC
    3,860 shares@ US$39.870.8% of flowCommon StockSEC:0001127602-21-009281:0
  • ▼
    VP-Corporate ControllerExecutivesCONMED Corp
    473,892 USD37SEC
    3,860 shares@ US$122.772.5% of flowCommon StockSEC:0001127602-21-009281:1
  • ◇
    VP-Corporate ControllerExecutivesCONMED Corp
    117,404 USD19SEC
    2,800 shares@ US$41.930.6% of flowCommon StockSEC:0001127602-21-009281:2
  • ▼
    VP-Corporate ControllerExecutivesCONMED Corp
    343,084 USD37SEC
    2,800 shares@ US$122.531.8% of flowCommon StockSEC:0001127602-21-009281:3
  • ◇
    VP-Corporate ControllerExecutivesCONMED Corp
    161,892 USD19SEC
    2,700 shares@ US$59.960.9% of flowCommon StockSEC:0001127602-21-009281:4
  • ▼
    VP-Corporate ControllerExecutivesCONMED Corp
    330,750 USD37SEC
    2,700 shares@ US$122.501.8% of flowCommon StockSEC:0001127602-21-009281:5
  • ◇
    VP-Corporate ControllerExecutivesCONMED Corp
    425,304 USD19SEC
    5,400 shares@ US$78.762.3% of flowCommon StockSEC:0001127602-21-009281:6
  • ▼
    VP-Corporate ControllerExecutivesCONMED Corp
    661,500 USD37SEC
    5,400 shares@ US$122.503.5% of flowCommon StockSEC:0001127602-21-009281:7
  • ◇
    VP-Corporate ControllerExecutivesCONMED Corp
    249,110 USD19SEC
    2,550 shares@ US$97.691.3% of flowCommon StockSEC:0001127602-21-009281:8
  • ▼
    VP-Corporate ControllerExecutivesCONMED Corp
    312,375 USD37SEC
    2,550 shares@ US$122.501.7% of flowCommon StockSEC:0001127602-21-009281:9
  • ▼
    VP-Corporate ControllerExecutivesCONMED Corp
    288,837 USD37SEC
    2,870 shares@ US$100.644.2% of flowCommon StockSEC:0001127602-20-031074:0
  • ▼
    VP-Corporate ControllerExecutivesCONMED Corp
    206,714 USD37SEC
    2,038 shares@ US$101.433.0% of flowCommon StockSEC:0001127602-20-031074:1
  • ◇
    VP-Corporate ControllerExecutivesCONMED Corp
    323,784 USD19SEC
    5,400 shares@ US$59.964.7% of flowCommon StockSEC:0001127602-20-031074:2
  • ▼
    VP-Corporate ControllerExecutivesCONMED Corp
    461,077 USD38SEC
    4,593 shares@ US$100.3876.7% of flowCommon StockSEC:0001127602-20-031074:3
  • ▼
    VP-Corporate ControllerExecutivesCONMED Corp
    81,886 USD37SEC
    807 shares@ US$101.471.2% of flowCommon StockSEC:0001127602-20-031074:4
  • ▼
    VP-Corporate ControllerExecutivesCONMED Corp
    213,025 USD37SEC
    2,061 shares@ US$103.363.1% of flowCommon StockSEC:0001127602-20-030331:0
  • ◇
    VP-Corporate ControllerExecutivesCONMED Corp
    140,466 USD19SEC
    3,350 shares@ US$41.932.1% of flowCommon StockSEC:0001127602-20-030331:1

25 of 105 declarations